Axogen Inc Quick Ratio (AXGN) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Axogen inc   (NASDAQ: AXGN)

Axogen Inc 's Quick Ratio

AXGN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 3.67 below Axogen Inc average.

Within Medical Equipment & Supplies industry 48 other companies have achieved higher Quick Ratio than Axogen Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 772 to 973.

Explain Quick Ratio?
How much Cash & cash equivalents AXGN´s has?
What are AXGN´s Current Liabilities?




AXGN Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change 33.39 % 21.57 % -26.04 % 21.23 % 5.11 %
Y / Y Cash & cash equivalent Change 272.34 % 360.38 % 24.03 % 45.91 % 41.59 %
Quick Ratio MRQ 3.67 4.25 1.96 1.39 1.31
AXGN's Total Ranking # 973 # 772 # 865 # 1044 # 927
Seq. Current Liabilities Change 27.1 % 12.81 % -17.48 % 12.74 % 15.83 %
Seq. Cash & cash equivalent Change 9.66 % 144.66 % 16.03 % 19.61 % 35.58 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 49
Healthcare Sector # 361
Overall Market # 973


Quick Ratio Statistics
High Average Low
17.15 4.39 0.46
(Sep 30 2013)   (Dec 31 2010)




Financial Statements
Axogen Inc 's Current Liabilities $ 30 Millions Visit AXGN's Balance sheet
Axogen Inc 's Cash & cash equivalent $ 111 Millions Visit AXGN's Balance sheet
Source of AXGN's Sales Visit AXGN's Sales by Geography


Cumulative Axogen Inc 's Quick Ratio

AXGN's Quick Ratio for the trailling 12 Months

AXGN Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 9.63 % 2.62 % -3.76 % -12.15 % -19.43 %
Y / Y Cash & cash equivalent TTM Growth 163.93 % 106.34 % 33.61 % 28.57 % 7.45 %
Quick Ratio TTM 2.87 2.23 1.45 1.25 1.19
Total Ranking TTM # 3799 # 2819 # 2475 # 2985 # 2142
Seq. Current Liabilities TTM Growth 8.13 % 4.75 % -7.71 % 4.87 % 1.21 %
Seq. Cash & cash equivalent TTM Growth 39.02 % 61.5 % 6.64 % 10.24 % 8.68 %


On the trailing twelve months basis AXGN Cash & cash equivalent more than doubled by 272.34 % in Q2 2026 year on year, faster than Current Liabilities, this led to increase in in Axogen Inc 's Quick Ratio to 2.87, Quick Ratio remained below AXGN average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 197 other companies have achieved higher Quick Ratio than Axogen Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 2819 to 3799.

Explain Quick Ratio?
How much Cash & cash equivalents AXGN´s has?
What are AXGN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 198
Healthcare Sector # 878
Within the Market # 3799


trailing twelve months Quick Ratio Statistics
High Average Low
9.84 3.2 0.53
(Mar 31 2014)   (Mar 31 2023)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Pulse Biosciences Inc   9.26 $ 101.620  Millions$ 10.978  Millions
Orchestra Biomed Holdings Inc   8.16 $ 109.963  Millions$ 13.471  Millions
Biolife Solutions Inc   8.11 $ 113.100  Millions$ 13.947  Millions
Bone Biologics Corporation  7.87 $ 4.032  Millions$ 0.512  Millions
Beyond Air Inc   7.68 $ 26.340  Millions$ 3.428  Millions
Talkspace Inc   7.62 $ 90.998  Millions$ 11.937  Millions
Safe Pro Group Inc   7.24 $ 10.231  Millions$ 1.413  Millions
Delcath Systems Inc   7.22 $ 95.902  Millions$ 13.279  Millions
Streamex Corp   7.16 $ 18.586  Millions$ 2.595  Millions
Endra Life Sciences Inc  7.04 $ 5.540  Millions$ 0.787  Millions
Iradimed Corporation  6.45 $ 59.080  Millions$ 9.164  Millions
Orasure Technologies Inc  6.39 $ 160.582  Millions$ 25.119  Millions
Alpha Pro Tech Ltd   5.94 $ 18.901  Millions$ 3.180  Millions
Si bone inc   5.89 $ 141.519  Millions$ 24.042  Millions
Dexcom Inc   5.84 $ 1,107.000  Millions$ 189.500  Millions
Cvrx inc   5.78 $ 64.586  Millions$ 11.177  Millions
Carlsmed Inc   5.67 $ 70.244  Millions$ 12.397  Millions
Profound Medical Corp   5.24 $ 38.271  Millions$ 7.304  Millions
Rxsight Inc   5.03 $ 404.247  Millions$ 80.444  Millions
Transmedics Group Inc   4.81 $ 472.675  Millions$ 98.283  Millions
Aethlon Medical Inc   4.76 $ 4.934  Millions$ 1.036  Millions
Bluejay Diagnostics Inc  4.53 $ 9.599  Millions$ 2.117  Millions
Hyperfine Inc   4.51 $ 43.458  Millions$ 9.629  Millions
Innovative Eyewear Inc   4.36 $ 2.455  Millions$ 0.563  Millions
Autonomix Medical Inc   4.23 $ 3.460  Millions$ 0.818  Millions
Sharps Technology Inc   4.16 $ 12.071  Millions$ 2.903  Millions
Trisalus Life Sciences Inc   4.14 $ 46.288  Millions$ 11.172  Millions
Kestra Medical Technologies Ltd   4.12 $ 198.911  Millions$ 48.269  Millions
Sight Sciences Inc   3.89 $ 79.753  Millions$ 20.499  Millions
Irhythm Holdings Inc   3.82 $ 839.951  Millions$ 219.981  Millions

Date modified: 2026-09-26T07:14:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.